← AmassCONTENT HISTORY

Update to Amass

Snapshot Oct 24, 2026 · 12:52 UTC · version 7.0.0

WHAT CHANGED

Package or technical metadata updated

Package or technical metadata updated

Observed in package metadata. These changes alone do not establish a new customer-facing feature.

Save Amass and check future changes in Following.

Up to 3 plugins free · no card required.

All fields and original values.

Is template instance

Before

Sep 30, 2026 · 22:49 UTC

Not present

After

Oct 24, 2026 · 12:52 UTC

false

Compare saved observations

Download comparison JSON
Full technical diff · 1 changed fields

added /is_template_instance

BEFORE
Field was absent
AFTER
false
Full snapshot data
{
  "canonical_app_id": "asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6",
  "connector_id": "asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6",
  "created_at": "2026-06-04T16:40:35.560229Z",
  "discoverability": "LISTED",
  "id": "plugin_asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6",
  "is_template": false,
  "is_template_instance": false,
  "name": "app-69fdb4eb74f08191a3deeac63eb3a0f6",
  "release": {
    "app_ids": [
      "asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6"
    ],
    "app_manifest": {
      "apps": {
        "app-69fdb4eb74f08191a3deeac63eb3a0f6": {
          "id": "asdk_app_69fdb4eb74f08191a3deeac63eb3a0f6",
          "required": true
        }
      }
    },
    "app_templates": [],
    "description": "Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.",
    "display_name": "Amass",
    "id": "pluginrel_98cc90d7e4a8819190e8d9db9be38d26",
    "interface": {
      "brand_color": null,
      "capabilities": [],
      "category": "Education & Research",
      "composer_icon_dark_url": "https://files.openai.com/content?id=file_0000000084a881f4903772380497f121",
      "composer_icon_url": "https://files.openai.com/content?id=file_0000000084a881f4903772380497f121",
      "default_prompt": "Map the current landscape for oral GLP-1 agonists in obesity — what's approved, what's in trials, and who holds patents.",
      "default_prompts": [
        "Map the current landscape for oral GLP-1 agonists in obesity — what's approved, what's in trials, and who holds patents.",
        "Make the case for and against KRAS G12D as a drug target: biology, what's been tried clinically, and failures.",
        "What happened to semaglutide since first approval — indication expansions, label changes, safety signals, and literature."
      ],
      "developer_name": "Amass Technologies ApS",
      "logo_url": "https://files.openai.com/content?id=file_00000000cad8821098365992fb3607d8",
      "logo_url_dark": "https://files.openai.com/content?id=file_0000000039b8820a9450b3dca0ffd8a0",
      "long_description": "Amass connects your assistant to six curated biomedical corpora: BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings), TrialCore (1.2M+ clinical trials from ClinicalTrials.gov and the WHO ICTRP), DrugCore (22K+ harmonized drugs/molecules covering modality, clinical stage, structure, synonyms, and the gene targets each drug acts on; ChEMBL-linked), RegulatoryCore (7K+ unified FDA + EMA marketing authorizations with source documents such as labels, reviews, SmPCs, and EPARs), GeneCore (43K+ harmonized human genes with a target-intelligence layer covering druggability, DepMap essentiality, ChEMBL target class, clinical-precedent tractability, curated safety liabilities, and gnomAD constraint), and PatentCore (preview, life-science patents with full-text search, CPC/IPC classifications, assignees/inventors, and patent families). Users can search and retrieve full records with filters that beat open-web retrieval, and follow cross-links across corpora back to each underlying source.",
      "plugin_category_id": "education & research",
      "privacy_policy_url": "https://amass.tech/legal/privacy-policy",
      "screenshot_urls": [],
      "short_description": "Life sciences intelligence",
      "terms_of_service_url": "https://amass.tech/legal/terms-of-service",
      "website_url": "https://amass.tech"
    },
    "keywords": [],
    "mcp_servers": [],
    "onboarding_skill_name": null,
    "requires_local_executor": false,
    "skills": [],
    "version": "7.0.0"
  },
  "scope": "GLOBAL",
  "share_url": "https://chatgpt.com/plugins/amass?open_in_app",
  "status": "ENABLED"
}

SHA-256 of public snapshot: fc75e898dd0567f33160f141d7f2d811cefb5dafb9607bf53abf990a0da9c9c3